18-80160089-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032510.4(PARD6G):āc.813C>Gā(p.Asp271Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000232 in 1,598,110 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032510.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARD6G | NM_032510.4 | c.813C>G | p.Asp271Glu | missense_variant | 3/3 | ENST00000353265.8 | NP_115899.1 | |
PARD6G-AS1 | NR_028339.1 | n.332-2427G>C | intron_variant | |||||
PARD6G-AS1 | NR_028340.1 | n.331+11835G>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARD6G | ENST00000353265.8 | c.813C>G | p.Asp271Glu | missense_variant | 3/3 | 1 | NM_032510.4 | ENSP00000343144.3 |
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 54AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000325 AC: 74AN: 227700Hom.: 1 AF XY: 0.000387 AC XY: 48AN XY: 124064
GnomAD4 exome AF: 0.000219 AC: 316AN: 1445816Hom.: 1 Cov.: 31 AF XY: 0.000241 AC XY: 173AN XY: 718048
GnomAD4 genome AF: 0.000355 AC: 54AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 26AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2022 | The c.813C>G (p.D271E) alteration is located in exon 3 (coding exon 3) of the PARD6G gene. This alteration results from a C to G substitution at nucleotide position 813, causing the aspartic acid (D) at amino acid position 271 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at